868
Participants
Start Date
July 31, 2015
Primary Completion Date
October 3, 2017
Study Completion Date
February 26, 2018
selepressin
placebo
Wake Forest University School of Medicine, Winston-Salem
Remington Davis Inc, Columbus
St Vincent Mercy Medical Center, Toledo
HealthPartners Speciality Clinics, Saint Paul
Northshore University Healthsystem Research Institute, Evanston
Rush University Medical Center, Chicago
Stormont Vail Health Care, Topeka
University of Nebraska Medical Center, Omaha
Memorial Hospital, Colorado Springs
Eastern Idaho Regional Medical Center, Idaho Falls
Baystate Medical Center, Springfield
Henry Ford Hospital, Detroit
University of Oklahoma Health Sciences Center, Oklahoma City
Temple University Hospital, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
Cliniques Universitaires Saint-Luc (there may be other sites in this country), Brussels
Aalborg Universitetshospital (there may be other sites in this country), Aalborg
Centre Hospitalier et Universitaire de Limoges (there may be other sites in this country), Limoges
Radboud University Nijmegen Medical Centre (there may be other sites in this country), Nijmegen
Cooper University Hospital, Camden
Ohio State University, Columbus
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY